People Spotlight — March 2022
The latest people news happenings over the past month
US Dept. of Justice Investigating HIV-drug Counterfeiting Ring, Says WSJ
Action follows on the heels of Gilead’s court actions against a $250-million scheme
Tower Cold Chain Launches Lightweight Container
KTEvolution “can easily be carried by one or two people”
KeyPlants Dispatches Vaccine Manufacturing Facility to Senegal
Will have capability of producing 300 million COVID-19 vaccines for Africa annually
Innovent, Lilly Expand Oncology Partnership in China
Deal features $45 million for commercialization of several Big Pharma products
Industry Readiness for DSCSA Compliance is “Progressing” but Far from Complete, says HDA
Trading partner Interconnections via the EPCIS standard is a basic requirement
RxS Moves into the Patient Support Arena
Company builds on its sample accountability platform
Moderna to Open mRNA Manufacturing Facility in Australia
Site construction is part of a 10-year agreement with the Australian government
Peli BioThermal Enhances Its Track-and-Trace Program
Crēdo ProEnvision Software 2.0, company says, expected to improve the customer experience for cold chain clients
Exothera Earns GMP Certification for Jumet Facility
Accreditation further extends CDMO's viral vector manufacturing capacity
Flamma Group Purchases API Site in Italy
Acquisition expected to be finalized in April
Healthcare Supply Chain Making Progress on EPCIS Implementation for DSCSA
Survey conducted by HDA reveals thought process of manufacturers, distributors, and 3PLs
COVID-19 Vaccine Manufacturers Submit Appeals to FDA for Additional Dose
Moderna, Pfizer, and BioNTech seeking FDA approval for fourth dose of their respective shots
MedaSystems Raises $1.5 Million Toward Furthering Patient Access to Investigational Therapies
Among benefits, Expanded Access software can reportedly help design more effective clinical trials and capture RWD
EVERSANA Launches Global Price and Market Access Solution
Platform combines data, software, and insights “into single ecosystem.”
IATA Publishes January Air Cargo Statistics
Latest report suggests a slower rate of growth and constrained capacity
First Commercial Shipment Using Releye RAP Container
Shipment from Basel, Switzerland, to JFK airport, New York, consisted of three Releye RAP units and two RAP e2 units.
UBC Announces Acquisition of MarketShare Movers
Acquisition of data-driven prescription drug benefit and affordability company will ”help patients overcome financial barriers to starting and staying on therapy.”
Amgen Begins Construction on North Carolina Manufacturing Facility
New center comes in response to increasing demand for firm’s medicines
UBC Doubles Down on Patient Support
Acquires MarketShare Movers, as company aims to provide patients with affordability services
CordenPharma to Boost Lipid Manufacturing Capabilities for mRNA Vaccine Production
CDMO’s Chenôve facility receives investment from French government
Sterling Pharma Purchases Novartis Manufacturing Site in Ireland
Deal expected to help expand its API production services
Moderna, Kenyan Government Sign Vaccine MoU
Agreement establishes company’s first mRNA manufacturing facility in Africa
Ashfield Acquires Research Partnership
Healthcare market research and insights company will become part of Ashfield Advisory.
Delpharm Purchases Sandoz Sterile Injectable Manufacturing Facility
The deal features a long-term supply and production agreement between the parties
Cambrex Grows Its Biopharma Offerings
Expansion features 11 new cGMP labs at Durham, NC location
EMA Recommends Approval of Spikevax for Children Aged 6 to 11
If given green light by European Commission, vaccine dose will be less than that of adolescents
Antares Vision Boosts Global Tracking System Software
GTS improvements include additional data integrity protection, greater Level 1 and 2 equipment compatibility
People spotlight — February 2022
Abzena, Alira Health, and Oncodesign Launch Specialist Services Consortium
New consortium provides integrated solution with specialist services, from biologics discovery to clinical and commercial manufacturing.
